eCite Digital Repository

Metformin improves vascular and metabolic insulin action in insulin resistant muscle


Bradley, EA and Premilovac, D and Betik, AC and Hu, D and Attrill, EH and Richards, SM and Keske, MA, Metformin improves vascular and metabolic insulin action in insulin resistant muscle, Journal of Endocrinology, 243, (2) pp. 85-96. ISSN 0022-0795 (2019) [Refereed Article]

Copyright Statement

Copyright 2019 Society for Endocrinology

DOI: doi:10.1530/JOE-19-0067


Insulin stimulates glucose disposal in skeletal muscle in part by increasing microvascular blood flow and this effect is blunted during insulin resistance. We aimed to determine whether metformin treatment improves insulin-mediated glucose disposal and vascular insulin responsiveness in skeletal muscle of insulin resistant rats. Sprague Dawley rats were fed a normal (ND) or high-fat (HFD) diet for four weeks. A separate HFD group was given metformin in drinking water (HFD+MF, 150 mg/kg/day) during the final two weeks. After the intervention, overnight-fasted (food and metformin removed) anaesthetised rats underwent a 2-hr euglycemic-hyperinsulinemic clamp (10 mU/min/kg) or saline infusion. Femoral artery blood flow, hindleg muscle microvascular blood flow, muscle glucose disposal and muscle signalling (Ser473-Akt and Thr172-AMPK phosphorylation) were measured. HFD rats had elevated body weight, epididymal fat pad weight, fasting plasma insulin and free fatty acid levels when compared to ND. HFD-fed animals displayed whole body and skeletal muscle insulin resistance and blunting of insulin-stimulated femoral artery blood flow, muscle microvascular blood flow and skeletal muscle insulin-stimulated Ser473-Akt phosphorylation. Metformin treatment of HFD rats reduced fasting insulin and non-esterified fatty acid concentrations and lowered body weight and adiposity. During hyperinsulinemic-euglycemic clamp, metformin-treated animals showed improved vascular responsiveness to insulin, improved insulin-stimulated muscle Ser473-Akt phosphorylation but only partially restored (60%) muscle glucose uptake. This occurred without any detectable levels of metformin in plasma or change in muscle Thr172-AMPK phosphorylation. We conclude that two-week metformin treatment is effective at improving vascular and metabolic insulin responsiveness in muscle of HFD-induced insulin resistant rats.

Item Details

Item Type:Refereed Article
Keywords:Insulin resistance, diabetes, metformin
Research Division:Biomedical and Clinical Sciences
Research Group:Medical physiology
Research Field:Systems physiology
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Bradley, EA (Miss Eloise Bradley)
UTAS Author:Premilovac, D (Dr Dino Premilovac)
UTAS Author:Hu, D (Mr Donghua Hu)
UTAS Author:Attrill, EH (Miss Emily Attrill)
UTAS Author:Richards, SM (Dr Stephen Richards)
UTAS Author:Keske, MA (Dr Michelle Keske)
ID Code:134857
Year Published:2019
Web of Science® Times Cited:10
Deposited By:Medicine
Deposited On:2019-09-10
Last Modified:2022-08-25

Repository Staff Only: item control page